• 1
    Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted? AIDS 2009; 23(4):485491.
  • 2
    Brookmeyer R, Gail MH. A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic. Journal of the American Statistical Association 1988; 83:301308.
  • 3
    Isham V. Mathematical-modeling of the transmission dynamics of HIV infection and AIDS—a review. Journal of the Royal Statistical Society Series A—Statistics in Society 1988; 151:530.
  • 4
    Ades AE, Medley GF. Estimates of disease incidence in women based on antenatal or neonatal seroprevalence data: HIV in New York City. Statistics in Medicine 1994; 13(18):18811894.
  • 5
    Kaplan E. Snapshot samples. Socio-Economic Planning Sciences 1997; 31:281291.
  • 6
    Karon JM, Song R, Brookmeyer R, Kaplan EH, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Statistics in Medicine 2008; 27(23):46174633.
  • 7
    Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Journal of the American Medical Association 1998; 280:4248.
  • 8
    Suligoi B, Massi M, Galli C, Sciandra M, Di Sora F, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. Journal of Acquired Immune Deficiency Syndromes 2003; 32:424428.
  • 9
    Chawla A, Murphy G, Donnelly C, Booth CL, Johnson M, Parry JV, PhillipS A, Geretti AM. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. Journal of Clinical Microbiology 2007; 45:415420.
  • 10
    De Gruttola V, Lagakos SW. Analysis of doubly-censored survival data, with application to AIDS. Biometrics 1989; 45(1):111.
  • 11
    Kim MY, De Gruttola V, Lagakos SW. Analyzing doubly censored data with covariates, with application to AIDS. Biometrics 1993; 49(1):1322.
  • 12
    Gentleman R, Vandal AC. Nonparametric estimation of the bivariate CDF for arbitrarily censored data. Canadian Journal of Statistics 2002; 30:557571.
  • 13
    Reich NG, Lessler J, Cummings DAT, Brookmeyer R. Estimating incubation period distributions with coarse data. Statistics in Medicine 2009; 28:27692784.
  • 14
    Turnbull BW. Empirical distribution function with arbitrarily grouped, censored and truncated data. Journal of the Royal Statistical Society Series B-Methodological 1976; 38:290295.
  • 15
    Maathuis M. MLEcens: Computation of the MLE for bivariate (interval) censored data. R Package Version 0.1-2, 2007. Available from:
  • 16
    Spiegelhalter D, Thomas A, Best NDL. WinBUGS Version 1.4 User Manual. MRC Biostatistics Unit, Cambridge, 2003.
  • 17
    Gelman A, Hill J. Data Analysis using Regression and Multilevel/Hierarchical Models. Cambridge University Press: Cambridge, 2007.
  • 18
    Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society Series B-Statistical Methodology 2002; 64:583616.
  • 19
    Galli C, Bossi V, Regine V, Rodella A, Manca N, Camoni L, Suligoi B. Accuracy of different thresholds for the anti-HIV avidity index. Microbiologia Medica 2008; 23:5963.
  • 20
    Parekh BS, Hu DJ, Vanichseni S, Satten GA, Candal D, Young NL, Kitayaporn D, Srisuwanvilai LO, Rakhtam S, Janssen R, Choopanya K, Mastro TD. Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Research and Human Retroviruses 2001; 17(5):453458.
  • 21
    Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Research and Human Retroviruses 2002; 18(4):295307.
  • 22
    McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Research and Human Retroviruses 2006; 22(10):945952.